====== Lead acetate 2000μM R08 exp498 no dilution day6 ====== ==== Mechanism of Action ==== Industrial pollutant, heavy metal toxin * **Class / Subclass 1:** Environmental Stresses / Heavy Metal ==== Technical Notes ==== * **PubChem Name:** %%Lead acetate trihydrate%% * **Synonyms:** N/A * **CAS #:** 6080-56-4 * **PubChem CID:** [[https://pubchem.ncbi.nlm.nih.gov/compound/22456|22456]] * **IUPAC:** %%lead(2+);diacetate;trihydrate%% * **INCHI Name:** InChI=1S/2C2H4O2.3H2O.Pb/c2*1-2(3)4;;;;/h2*1H3,(H,3,4);3*1H2;/q;;;;;+2/p-2 * **INCHI Key:** MCEUZMYFCCOOQO-UHFFFAOYSA-L * **Molecular Weight:** 379 * **Canonical SMILES:** CC(=O)[O-].CC(=O)[O-].O.O.O.[Pb+2] * **Isomeric SMILES:** N/A * **Molecular Formula:** C4H12O7Pb {{:chemogenomics:structures:chem-0304.svg?nolink}} * **Supplier Name:** EM Science * **Catalog #:** LX0120-1 * **Lot #:** 28147208 * **XRPD:** Expected Pb(CH3COO)2 3H2O; found Pb(CH3COO)2 + Pb(CH3COO)2 3H2O * **Platform ID:** Lead-Aceteate * **Min:** 2.9017; **Max:** 98.7157 {{:chemogenomics:dose_response:dr_435.png?nolink&500 |}} \\ \\ \\ \\ |< 300px 100px 200px >| ^ IC ^ Concentration (µM) ^ | IC10 |N/A | | IC20 |1.3598 | | IC30 |2.1266 | | IC40 |3.0284 | | IC50 |4.1663 | | IC60 |N/A | | IC70 |N/A | | IC80 |N/A | | IC90 |N/A | \\ ==== Screen Summary ==== * **Round**: 08 * **Dose**: 2000µM * **Days of incubation**: 8 * **Doublings**: 2.0 * **Numbers of reads**: 16475946 ==== Screen Results ==== ^Sensitive/Resistant hits (FDR<0.05)^CRANKS^Score Plot^Top 30 Genes^Screen Similarity^Top 30 Sensitive GO terms^Top 30 Resistant GO terms^ |21/63|[[https://files.tyerslab.com/files/public/chemogenomics/cranks/Lead_acetate_2000uM_Round-8_exp498.txt|Scores]]|||||| {{:chemogenomics:cranks_plots:exp498.png?nolink}} ^Gene^CRANKS Score^FDR^ |[[:human_genes:T:TMEM165|TMEM165]]|-4.01|<0.01| |[[:human_genes:B:BACH2|BACH2]]|-3.34|<0.01| |[[:human_genes:Q:QRICH1|QRICH1]]|-3.12|<0.01| |[[:human_genes:T:TCF4|TCF4]]|-3.00|<0.01| |[[:human_genes:D:DDX47|DDX47]]|-2.95|0.08| |[[:human_genes:U:UXS1|UXS1]]|-2.89|<0.01| |[[:human_genes:F:FDFT1|FDFT1]]|-2.73|0.01| |[[:human_genes:K:KEAP1|KEAP1]]|-2.72|0.03| |[[:human_genes:K:KDSR|KDSR]]|-2.65|0.02| |[[:human_genes:B:BCL11A|BCL11A]]|-2.63|0.02| |[[:human_genes:A:ACBD3|ACBD3]]|-2.60|0.06| |[[:human_genes:S:SEPHS1|SEPHS1]]|-2.59|0.03| |[[:human_genes:A:ATP1B4|ATP1B4]]|-2.53|0.05| |[[:human_genes:E:ELAVL1|ELAVL1]]|-2.51|0.03| |[[:human_genes:F:FDPS|FDPS]]|-2.50|0.05| |[[:human_genes:A:ACTR10|ACTR10]]|-2.49|0.05| |[[:human_genes:S:SOX4|SOX4]]|-2.48|0.09| |[[:human_genes:S:SUPT7L|SUPT7L]]|-2.47|0.05| |[[:human_genes:E:EP300|EP300]]|-2.45|0.15| |[[:human_genes:T:TTC7A|TTC7A]]|-2.44|0.04| |[[:human_genes:Z:ZNF770|ZNF770]]|-2.44|0.04| |[[:human_genes:C:CNOT2|CNOT2]]|-2.41|0.05| |[[:human_genes:P:PTDSS1|PTDSS1]]|-2.40|0.05| |[[:human_genes:S:SIAH1|SIAH1]]|-2.36|0.05| |[[:human_genes:Z:ZBTB10|ZBTB10]]|-2.34|0.05| |[[:human_genes:R:RSRC2|RSRC2]]|-2.33|0.35| |[[:human_genes:M:MTMR11|MTMR11]]|-2.31|0.05| |[[:human_genes:S:SKA1|SKA1]]|-2.29|0.06| |[[:human_genes:I:IGSF23|IGSF23]]|-2.27|0.10| |[[:human_genes:L:LRRC16B|LRRC16B]]|-2.24|0.07| |[[:human_genes:M:MAGT1|MAGT1]]|2.71|<0.01| |[[:human_genes:S:STT3B|STT3B]]|2.74|<0.01| |[[:human_genes:C:CXorf56|CXorf56]]|2.78|<0.01| |[[:human_genes:P:PIH1D1|PIH1D1]]|2.83|<0.01| |[[:human_genes:S:SAP130|SAP130]]|2.85|<0.01| |[[:human_genes:A:AKT1|AKT1]]|2.86|<0.01| |[[:human_genes:N:NF1|NF1]]|2.87|<0.01| |[[:human_genes:E:EIF3F|EIF3F]]|2.90|<0.01| |[[:human_genes:A:AKT2|AKT2]]|2.94|<0.01| |[[:human_genes:A:AXIN1|AXIN1]]|2.99|<0.01| |[[:human_genes:K:KCTD5|KCTD5]]|3.11|0.00| |[[:human_genes:P:PRRC2C|PRRC2C]]|3.11|<0.01| |[[:human_genes:B:BAK1|BAK1]]|3.18|0.00| |[[:human_genes:C:C12orf49|C12orf49]]|3.41|0.00| |[[:human_genes:V:VPS37B|VPS37B]]|3.42|0.00| |[[:human_genes:B:BRMS1|BRMS1]]|3.45|0.00| |[[:human_genes:M:MEMO1|MEMO1]]|3.45|0.00| |[[:human_genes:A:ARID4B|ARID4B]]|3.48|0.00| |[[:human_genes:C:CTNNBIP1|CTNNBIP1]]|3.51|0.00| |[[:human_genes:R:RICTOR|RICTOR]]|3.65|0.00| |[[:human_genes:H:HEXIM1|HEXIM1]]|3.80|0.00| |[[:human_genes:F:FBXO11|FBXO11]]|3.87|0.00| |[[:human_genes:P:PPP6C|PPP6C]]|3.97|0.00| |[[:human_genes:I:ING1|ING1]]|4.16|0.00| |[[:human_genes:L:LZTR1|LZTR1]]|4.28|0.00| |[[:human_genes:M:MAPKAP1|MAPKAP1]]|4.35|0.00| |[[:human_genes:C:CMIP|CMIP]]|4.44|0.00| |[[:human_genes:E:EIF4A1|EIF4A1]]|4.50|0.00| |[[:human_genes:K:KMT2D|KMT2D]]|4.56|0.00| |[[:human_genes:S:SCAP|SCAP]]|7.22|0.00| ^Screen^Correlation^Plot^ |[[:results:exp242|Radicicol 0.16μM R05 exp242]]|0.075|| |[[:results:exp407|Thapsigargin 0.005μM R07 exp407]]|0.075|| |[[:results:exp525|Sulforaphane 9μM R08 exp525]]|0.069|| |[[:results:exp492|iCRT14 30μM R08 exp492]]|0.066|| |[[:results:exp526|Sulforaphane 9μM R08 exp526 no dilution day6]]|0.065|| |[[:results:exp502|Milciclib 2μM R08 exp502]]|0.06|| |[[:results:exp535|Trimetrexate 0.03μM R08 exp535]]|0.058|| |[[:results:exp517|Quercetin 20μM R08 exp517]]|0.057|| |[[:results:exp134|MS023 2μM R03 exp134]]|0.056|| |[[:results:exp30|Rapamycin 10μM R00 exp30]]|0.056|| |[[:results:exp36|TRAIL 50ng/ml R00 exp36]]|0.055|| |[[:results:exp294|Nutlin-3A 1.6μM R06 exp294]]|0.055|| |[[:results:exp512|Olaparib 4μM R08 exp512]]|0.054|| |[[:results:exp520|Rucaparib 6.5μM R08 exp520]]|0.051|| |[[:results:exp497|Lead acetate 2000μM R08 exp497]]|0.36|| |[[:results:exp234|Ethanol 0.01 R05 exp234]]|0.108|| |[[:results:exp485|GSK626616 14μM R08 exp485]]|0.07|| |[[:results:exp453|B02 10μM R08 exp453]]|0.069|| |[[:results:exp342|Calcium Ionophore 0.4μM R07 exp342]]|0.068|| |[[:results:exp489|Hippuristanol 0.12μM R08 exp489 no dilution day6]]|0.061|| |[[:results:exp456|Benzoate 20000μM R08 exp456]]|0.058|| |[[:results:exp488|Hippuristanol 0.12μM R08 exp488]]|0.057|| |[[:results:exp354|Diepoxybutane 3μM R07 exp354]]|0.056|| |[[:results:exp116|AICAR 240μM R03 exp116]]|0.054|| |[[:results:exp359|FK-506 30μM R07 exp359]]|0.052|| |[[:results:exp365|I-BRD9 4μM R07 exp365]]|0.051|| |[[:results:exp334|All-trans-Retinoic-Acid 40μM R07 exp334]]|0.051|| {{:chemogenomics:comparison_plots:exp242_vs_exp498.png?nolink |}} {{:chemogenomics:comparison_plots:exp407_vs_exp498.png?nolink |}} {{:chemogenomics:comparison_plots:exp498_vs_exp525.png?nolink |}} {{:chemogenomics:comparison_plots:exp492_vs_exp498.png?nolink |}} {{:chemogenomics:comparison_plots:exp498_vs_exp526.png?nolink |}} {{:chemogenomics:comparison_plots:exp498_vs_exp502.png?nolink |}} {{:chemogenomics:comparison_plots:exp498_vs_exp535.png?nolink |}} {{:chemogenomics:comparison_plots:exp498_vs_exp517.png?nolink |}} {{:chemogenomics:comparison_plots:exp134_vs_exp498.png?nolink |}} {{:chemogenomics:comparison_plots:exp30_vs_exp498.png?nolink |}} {{:chemogenomics:comparison_plots:exp36_vs_exp498.png?nolink |}} {{:chemogenomics:comparison_plots:exp294_vs_exp498.png?nolink |}} {{:chemogenomics:comparison_plots:exp498_vs_exp512.png?nolink |}} {{:chemogenomics:comparison_plots:exp498_vs_exp520.png?nolink |}} {{:chemogenomics:comparison_plots:exp497_vs_exp498.png?nolink |}} {{:chemogenomics:comparison_plots:exp234_vs_exp498.png?nolink |}} {{:chemogenomics:comparison_plots:exp485_vs_exp498.png?nolink |}} {{:chemogenomics:comparison_plots:exp453_vs_exp498.png?nolink |}} {{:chemogenomics:comparison_plots:exp342_vs_exp498.png?nolink |}} {{:chemogenomics:comparison_plots:exp489_vs_exp498.png?nolink |}} {{:chemogenomics:comparison_plots:exp456_vs_exp498.png?nolink |}} {{:chemogenomics:comparison_plots:exp488_vs_exp498.png?nolink |}} {{:chemogenomics:comparison_plots:exp354_vs_exp498.png?nolink |}} {{:chemogenomics:comparison_plots:exp116_vs_exp498.png?nolink |}} {{:chemogenomics:comparison_plots:exp359_vs_exp498.png?nolink |}} {{:chemogenomics:comparison_plots:exp365_vs_exp498.png?nolink |}} {{:chemogenomics:comparison_plots:exp334_vs_exp498.png?nolink |}} No GO term hits below threshold. (FDR <0.05) ^GO Term^Fold Change^Genes^ |negative regulation of long-chain fatty acid import into cell|368.20|AKT2,AKT1| |negative regulation of long-chain fatty acid import across plasma membrane|368.20|AKT2,AKT1| |Sin3-type complex|105.20|ING1,ARID4B,BRMS1,SAP130| |Sin3 complex|105.20|ING1,ARID4B,BRMS1,SAP130| |negative regulation of stem cell population maintenance|92.05|ING1,ARID4B,BRMS1,SAP130| |myelination in peripheral nervous system|63.73|AKT2,NF1,AKT1| |peripheral nervous system axon ensheathment|63.73|AKT2,NF1,AKT1| |Schwann cell development|57.13|AKT2,NF1,AKT1| |positive regulation of stem cell population maintenance|47.00|ING1,ARID4B,BRMS1,SAP130| |regulation of stem cell population maintenance|31.56|ING1,ARID4B,BRMS1,SAP130| |histone deacetylase complex|27.62|ING1,ARID4B,BRMS1,SAP130| |negative regulation of transforming growth factor beta receptor signaling pathway|24.55|ING1,ARID4B,BRMS1,SAP130| |regulation of peptidyl-serine phosphorylation|21.08|MAPKAP1,RICTOR,BAK1,AXIN1,AKT1| |regulation of transforming growth factor beta receptor signaling pathway|20.31|ING1,ARID4B,BRMS1,AXIN1,SAP130| |regulation of cellular response to transforming growth factor beta stimulus|19.87|ING1,ARID4B,BRMS1,AXIN1,SAP130| |negative regulation of cell migration|11.96|ING1,ARID4B,BRMS1,NF1,AKT1,SAP130| |negative regulation of cell motility|11.35|ING1,ARID4B,BRMS1,NF1,AKT1,SAP130| |negative regulation of locomotion|10.13|ING1,ARID4B,BRMS1,NF1,AKT1,SAP130| |regulation of protein phosphorylation|6.63|MAPKAP1,HEXIM1,RICTOR,BAK1,AXIN1,AKT2,NF1,AKT1,PIH1D1,EIF2AK3,PHIP|